Monthly revenue and year-on-year change for GREATWALL (1210) and Gin Hwa Biotech (7806) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | GREATWALL | YoY | Gin Hwa Biotech | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$9.66 billion | +14.6% | NT$35.7 million | -9.0% |
| Sep 2026 | NT$9.88 billion | +13.2% | NT$47.7 million | +41.5% |
| Aug 2026 | NT$9.7 billion | +13.4% | NT$45.7 million | -8.6% |
| Jul 2026 | NT$9.64 billion | +21.5% | NT$44 million | +27.0% |
| Jun 2026 | NT$8.95 billion | +12.2% | NT$48.8 million | +13.5% |
| May 2026 | NT$9.07 billion | +10.2% | NT$48.4 million | -0.7% |
| Apr 2026 | NT$9.1 billion | +4.3% | NT$49 million | +12.6% |
| Mar 2026 | NT$9.21 billion | +5.0% | NT$55.4 million | -29.0% |
| Feb 2026 | NT$7.63 billion | -5.7% | NT$33.8 million | -7.9% |
| Jan 2026 | NT$9.73 billion | +12.0% | NT$46.8 million | +37.1% |
| Dec 2025 | NT$9.59 billion | +4.6% | NT$49.1 million | +16.9% |
| Nov 2025 | NT$8.86 billion | -1.2% | NT$47.8 million | +29.1% |
| Oct 2025 | NT$8.43 billion | -2.0% | NT$39.2 million | +14.3% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16